Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.39 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3147087 | 0.99 | MAPT (0.46) | MAPTKDM4ESMN1; SMN2HTTTDP1 | |
| SCHEMBL4809503 | 0.87 | HSD17B10 (0.43) | MAPTKDM4ESMN1; SMN2HTTTDP1 | |
| SCHEMBL6279991 | 0.87 | HSD17B10 (0.43) | MAPTKDM4ESMN1; SMN2HSD17B10ALDH1A1 | |
| SCHEMBL3152628 | 0.86 | HSD17B10 (0.42) | MAPTKDM4ESMN1; SMN2TDP1GAA | |
| SCHEMBL13980917 | 0.83 | CNR1 (0.43) | KDM4ESMN1; SMN2HTTGAACNR1 | |
| SCHEMBL3146828 | 0.82 | CNR1 (0.43) | KDM4ESMN1; SMN2HTTGAACNR1 | |
| SCHEMBL13478938 | 0.82 | CNR1 (0.43) | KDM4ESMN1; SMN2HTTGAACNR1 | |
| SCHEMBL23367943 | 0.81 | MAPT (0.55) | MAPTKDM4ESMN1; SMN2HTTTDP1 | |
| SCHEMBL5163362 | 0.80 | MAPT (0.54) | MAPTKDM4ESMN1; SMN2HTTTDP1 | |
| SCHEMBL23367944 | 0.80 | MEN1 (0.56) | MAPTKDM4ESMN1; SMN2HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7470793-B2 | Thiazol-(bi)cycloalkyl-carboxanilides | BAYER CROPSCIENCE AG (DE) | 2008-12-30 | — | — | US | disclosed |
| US-20060155122-A1 | Thiazol-(bi)cycloalkyl-carboxanilides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2006-07-13 | — | — | US | disclosed |
| EP-1558592-A1 | THIAZOL-(BI)CYCLOALKYL-CARBOXANILIDES | Bayer CropScience Aktiengesellschaft (DE) | 2005-08-03 | — | — | EP | disclosed |
| WO-2004039789-A1 | THIAZOL-(BI)CYCLOALKYL-CARBOXANILIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2004-05-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060155122-A1 | Thiazol-(bi)cycloalkyl-carboxanilides | MRPL21, Q6ZSR9, QPCT | MAPT 2676/4885KDM4E 4438/4885SMN1; SMN2 4244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.